INHIBRX INC's ticker is INBX and the CUSIP is 45720L107. A total of 67 filers reported holding INHIBRX INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $131,217,657 | -23.9% | 7,150,826 | +7.7% | 0.53% | -24.6% |
| Q2 2023 | $172,353,606 | +37.6% | 6,639,199 | 0.0% | 0.71% | +20.1% |
| Q1 2023 | $125,281,685 | -23.4% | 6,639,199 | 0.0% | 0.59% | -28.2% |
| Q4 2022 | $163,589,863 | +71.8% | 6,639,199 | +25.1% | 0.82% | +86.1% |
| Q3 2022 | $95,240,000 | +58.1% | 5,305,866 | 0.0% | 0.44% | +60.0% |
| Q2 2022 | $60,222,000 | -49.1% | 5,305,866 | 0.0% | 0.28% | -42.5% |
| Q1 2022 | $118,215,000 | -49.0% | 5,305,866 | 0.0% | 0.48% | -28.4% |
| Q4 2021 | $231,707,000 | +31.1% | 5,305,866 | 0.0% | 0.67% | +37.7% |
| Q3 2021 | $176,738,000 | +21.0% | 5,305,866 | 0.0% | 0.48% | +9.5% |
| Q2 2021 | $146,017,000 | +37.1% | 5,305,866 | 0.0% | 0.44% | +39.7% |
| Q1 2021 | $106,489,000 | -39.1% | 5,305,866 | 0.0% | 0.32% | -34.1% |
| Q4 2020 | $174,934,000 | +83.2% | 5,305,866 | 0.0% | 0.48% | +39.4% |
| Q3 2020 | $95,506,000 | – | 5,305,866 | – | 0.34% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM BioImpact LLC | 1,286,435 | $31,697,758 | 8.22% |
| Perceptive Advisors | 3,313,783 | $81,651,613 | 2.29% |
| RA Capital Management | 3,853,867 | $94,959,283 | 1.93% |
| Soleus Capital Management, L.P. | 478,302 | $11,785,361 | 1.69% |
| Sofinnova Investments, Inc. | 1,110,183 | $27,354,909 | 1.62% |
| Birchview Capital, LP | 70,448 | $1,736 | 1.23% |
| VIKING GLOBAL INVESTORS LP | 6,639,199 | $163,589,863 | 0.82% |
| Meridian Wealth Advisors, LLC | 122,315 | $3,013,842 | 0.78% |
| Gyon Technologies Capital Management, LP | 44,074 | $1,085,983 | 0.41% |
| ArrowMark Colorado Holdings LLC | 1,139,337 | $28,073,264 | 0.34% |